Search results (7)
« Back to NewsMachine Learning Predicts SETD2 Mutation Status with Unprecedented Accuracy using DNA methylation
11 August 2023
In a pan-cancer analysis spanning 24 different cancer type, researchers shed light on the critical role of SETD2 in tumourigenesis.
New Oxford and Nottingham developed tool uses existing health records to predict people’s risk of developing lung cancer within the next 10 years
6 April 2023
Innovation Publication Research
A team of researchers from the University of Oxford and the University of Nottingham have developed a new tool, called ‘CanPredict’, aimed at identifying the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives.
Tackling the serious side effects of cancer treatment in an ageing population
20 August 2020
Prof. Anne Kiltie and her team discuss their important work into the effects of radiosensitisation on ageing cancer patients with the CRUK Science Blog.
Ramandan Group publish original scientific article in Nature Communications
9 March 2020
Group of Professor Kristijan Ramadan has published an original scientific article in Nature Communications today. The article has the first report of a new autophagy receptor TEX264, which may be involved in tumours developing drug resistance.
A tempting new target for cancer therapy
15 October 2019
DNA Damage & Repair Publication Research
Kristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.
The Tarsounas group publish two outstanding papers
25 July 2019
Madalena Tarsounas' group have recently published two new papers in EMBO Molecular Medicine and Nature Communications.
SPRTN protease and checkpoint kinase 1 cross-activation loop safeguards DNA replication
18 July 2019
Kristijan Ramadan's group have published a new paper which shows how cells keep the DNA replication machinery moving when faced with blockers.